AMFPMC -- An improved method of detecting multiple types of drug-drug interactions using only known drug-drug interactions
Adverse drug interactions are largely preventable causes of medical accidents, which frequently result in physician and emergency room encounters. The detection of drug interactions in a lab, prior to a drug's use in medical practice, is essential, however it is costly and time-consuming. Machine learning techniques can provide an efficient and accurate means of predicting possible drug-drug interactions and combat the growing problem of adverse drug interactions. Most existing models for predicting interactions rely on the chemical properties of drugs. While such models can be accurate, the required properties are not always available.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Graph Distance Neural Networks for Predicting Multiple Drug Interactions
Since multidrug combination is widely applied, the accurate prediction of drug-drug interaction (DDI) is becoming more and more critical. In our method, we use graph to represent drug-drug interaction: nodes represent dr…
Link PredictionPredictionAggregate-Eliminate-Predict: Detecting Adverse Drug Events from Heterogeneous Electronic Health Records
We study the problem of detecting adverse drug events in electronic healthcare records. The challenge in this work is to aggregate heterogeneous data types involving diagnosis codes, drug codes, as well as lab measuremen…
feature selectionDetection of Adverse Drug Reaction in Tweets Using a Combination of Heterogeneous Word Embeddings
This paper details our approach to the task of detecting reportage of adverse drug reaction in tweets as part of the 2019 social media mining for healthcare applications shared task. We employed a combination of three ty…
Word EmbeddingsDreamDrug - A crowdsourced NER dataset for detecting drugs in darknet markets
We present DreamDrug, a crowdsourced dataset for detecting mentions of drugs in noisy user-generated item listings from darknet markets. Our dataset contains nearly 15,000 manually annotated drug entities in over 3,500 i…
NERMSCoD: An Enhanced Bayesian Updating Framework with Multi-Scale Information Bottleneck and Cooperative Attention for Structure-Based Drug Design
Structure-Based Drug Design (SBDD) is a powerful strategy in computational drug discovery, utilizing three-dimensional protein structures to guide the design of molecules with improved binding affinity. However, capturin…
Drug Discovery